Abstract:Abstract Background Patients with acute severe ulcerative colitis (ASUC) are at increased risk of colectomy following an episode of acute severe exacerbation. Medical rescue therapy in steroid non-responders has reduced the need for emergency colectomy. However, impact of biologics on longer-term colectomy risk is unclear. Methods A retrospective cohort study of adult patients aged ≥18 years hospitalized with acute exacerbation of UC requiring hospitalization and managed with intravenous corticosteroids between 2010 and 2022 at two regional hospitals in London, Ontario, Canada. Steroid non-response was defined as requirement of medical rescue therapy or colectomy. Results A total of 264 adults hospitalized with ASUC were included in the analysis (male: 51.1% [n=136], mean age at admission: 40.8±17.8 years). The majority had extensive colitis (71.3% [n=169]) at the time of diagnosis. 46.3% (n=118/255) presented within one year of disease onset and 23% (n=61) had ASUC as their first presentation with UC. 25.7% (n=66/257) of patients had prior purine analogues and 23.3% (60/257) had previous biologics prior to ASUC presentation. After admission, 55.7% (n=147) responded to intravenous corticosteroids. Of the steroid non-responders, 37.5% (n=99) patients were managed with infliximab rescue therapy and only one patient received tofacitinib rescue therapy. Median CRP, stool frequency and Lindgren index score were statistically significant between steroid responders and non-responders (Table 1). A higher proportion of steroid non-responders had prior exposure to biologics or tofacitinib compared to steroid responders (31.9% vs 16.3%, p<0.01). On multivariate analysis for various factors predicting steroid non-response, assessment by Oxford criteria on day 3 was the only factor that was statistically significant (odds ratio 4.70 (95% CI 1.06-20.8), p = 0.04). Oxford criteria on day 3 had a sensitivity, specificity of 58.6% and70.8%, respectively for predicting steroid non-response. 8% (n=21) required colectomy during index admission. An additional 13% (n = 32) underwent colectomy within 12 months of discharge, for which there was no difference between steroid responders and non-responders (12.2% vs 14.7%). The short term (3 months following discharge) and long-term (3-12 months following discharge) colectomy rates following discharge were 8% (20/245) and 5.4% (12/223) respectively. Hospitalization with UC exacerbation rate following discharge was 17% (38/223). Conclusion 8% of patients admitted for ASUC require colectomy during the same admission and additional 13% required colectomy within 12 months of discharge. Despite a high initial response to corticosteroids, long term colectomy rates and re-hospitalization rates remain high.

The impact of smoking and smoking cessation on disease outcomes in ulcerative colitis: a nationwide population‐based study

Smoking status at diagnosis and subsequent smoking cessation: associations with corticosteroid use and intestinal resection in crohn's disease

The Impact of Smoking on Ulcerative Colitis and Interaction With Family History: A Population‐Based Cohort Study

Differential Impact of Smoking on Methylome and Transcriptome in Crohn's Disease and Ulcerative Colitis

Assessing Progression of Biologic Therapies Based on Smoking Status in Patients With Crohn's Disease

The impact of tobacco smoking on treatment choice and efficacy in inflammatory bowel disease

P1180 Smoking behaviour and changes after diagnosis in patients with Crohn's disease in a tertiary referral hospital: A retrospective explorative study

Smoking Status and Survival Among a National Cohort of Lung and Colorectal Cancer Patients

Corticosteroid Therapy in Ulcerative Colitis: Clinical Response and Predictors.

Periodontitis combined with smoking increases risk of the ulcerative colitis: A national cohort study

Impact of Cigarette Smoking on Clinical Presentation and Treatment Response in Coeliac Disease

Smoking and Inflammatory Bowel Disease: A Comparison of China, India, and the USA

Has Smoking Changed the Epidemiology of Ulcerative Colitis?

Smoking and colorectal neoplasia in patients with inflammatory bowel disease: Dose-effect relationship

Natural History of Adult Ulcerative Colitis in Population-based Cohorts: A Systematic Review

P550 Short and long-term outcomes after acute severe ulcerative colitis in adults: A 12 year Canadian experience in the post biologic era

Disease Severity in Never Smokers, Ex-Smokers, and Current Smokers With Axial Spondyloarthritis: Results From the Scotland Registry for Ankylosing Spondylitis

Smoking Behavior and Prognosis After Colorectal Cancer Diagnosis: A Pooled Analysis of 11 Studies

Association between antidepressant medication use and steroid dependency in patients with ulcerative colitis: a population-based study

The impact of timing and duration of thiopurine treatment on colectomy in ulcerative colitis: a national population‐based study of incident cases between 1989–2009

Impact of Maternal Smoking, Offspring Smoking, and Genetic Susceptibility on Crohn's Disease and Ulcerative Colitis.